Failure to collaborate could also lead to hoarding within the nation which successfully develops the first successful vaccine, followed by intense competition between wealthy states for remaining vaccines. Instead, covax has guaranteed equitable distribution to all participating nations, ensuring vaccination of a minimum of 20% of the population, namely those who meet at-risk criteria. It is also notable that having vaccines distributed across economic zones will be more helpful in rebooting the international economy than having a handful of nation with high rates of vaccination at the expense of other nations. The group aims to produce 2 billion doses of the vaccine by the end of 2021.